However, no significant difference in DNA methylation at the PRF1 locus was observed between patients with non-muscle-invasive (stage I) and those with muscle-invasive (stage ≥II) tumors, suggesting that PRF1remains transcriptionally active across both early and advanced tumor stages. The gene discussed is PRF1; the disease is neoplasm.